Penn Medicine Provider
Endocrine and Oncologic Surgery
Giorgos C. Karakousis, MD
4.9
(578)
Accepting new patients
Sees patients age 18 and up
Penn Endocrine and Oncologic Surgery Perelman 3rd Floor
Make an appointmentCall 215-614-1963

About me

  • Chief, Division of Endocrine and Oncologic Surgery
  • The Emilie and Roland T. deHellenbranth Professor in Surgery II

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania
  • Fellowship: Memorial Sloan-Kettering Cancer Center

What my patients think about me

Average Rating
4.9

587 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
explained everything to me clearly.
May 2025
5.0
5.0
great bedside manner
May 2025
5.0
5.0
dr k is the best!
May 2025
5.0
5.0
doctor's were outstanding.

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Karakousis is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Wagner P, Levine EA, Kim AC, Shen P, Fleming ND, Westin SN, Berry LK, Karakousis GC, Tanyi JL, Olson MT, Madajewski B, Ostrander B, Krishnan K, Balch CM, Bartlett DL Detection of residual peritoneal metastases following cytoreductive surgery using pegsitacianine, a pH-sensitive imaging agent: Final results from a phase II study , Annals of Surgical Oncology: 2024 (Epub)

Tortorello GN, Li EH, Sharon CE, Shafique N, Chu EY, Ming ME, Karakousis GC Pathologic characteristics and clinical outcomes of primary dermal melanoma , Journal of the American Academy of Dermatology: 2024 (Epub)

Sharon CE, Karakousis GC Neoadjuvant therapy for resectable melanoma , Clinical & Experimental Metastasis: 2024 (Epub)

Maker AV, Karakousis G Educating cancer-associated fibroblasts (CAFs): Are they the student or the teacher? , Annals of Surgical Oncology, 31(4): 2024,2181-2182

Vargas GM, Shafique N, Xu X, Karakousis G Tumor-infiltrating lymphocytes as a prognostic and predictive factor for melanoma , Expert Review of Molecular Diagnostics, 24(4): 2024,299-310

Miura J, Sabharwal S, Ghert M, Karakousis G, Roland CL Great debate: Systematic re-resection after macroscopic complete unplanned excision of soft tissue sarcoma , Annals of Surgical Oncology, 31(3): 2024,2047-2050

Straker RJ 3rd, El Jack AK, Karakousis GC, Sharon CE, Ahmad NA, DeMatteo RP, Roses RE Clinical features can distinguish gastrointestinal stromal tumor from other subepithelial gastric tumors , Journal of Gastrointestinal Surgery, 28(3): 2024,276-278

Ma KL, Sharon CE, Tortorello GN, Keele L, Lukens JN, Karakousis GC, Miura JT Delayed time to radiation and overall survival in Merkel cell carcinoma , Journal of Surgical Oncology, 128(8): 2023,1385-1393

Sharon CE, Karakousis GC Educational Review: Neoadjuvant approaches to melanoma , Annals of Surgical Oncology, 29(13): 2023,8492-8500

Wang K, Coutifaris P, Brocks D, Solis S, Han N, Manne S, Kiner E, Sachar C, George S, Yan P, Kiner MW, Laughlin AI, Kothari S, Giles JR, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney D, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Wherry EJ, Minn A, Weber J, Mitchell T, Herati RS, Huang A Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade , Journal for ImmunoTherapy of Cancer, 11(Suppl 2): 2023,A1759